INNOVATOR ETFS TRUST - IBD BREAKOUT (BOUT)

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / IBD BREAKOUT
Total 13F shares
66,460
Share change
+6,240
Total reported value
$2,518,832
Price per share
$37.91
Number of holders
14
Value change
+$231,805
Number of buys
4
Number of sells
4

Institutional Holders of INNOVATOR ETFS TRUST - IBD BREAKOUT (BOUT) as of Q1 2022

As of 31 Mar 2022, INNOVATOR ETFS TRUST - IBD BREAKOUT (BOUT) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 66,460 shares. The largest 10 holders included SUSQUEHANNA INTERNATIONAL GROUP, LLP, Wealthcare Advisory Partners LLC, Csenge Advisory Group, CITADEL ADVISORS LLC, ADVISOR GROUP HOLDINGS, INC., Patriot Financial Group Insurance Agency, LLC, American Portfolios Advisors, MORGAN STANLEY, UBS Group AG, and Asset Dedication, LLC. This page lists 14 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.